miR-27b inhibits gastric cancer metastasis by targeting NR2F2

Abstract

Increasing attention is focused on the down-regulation of miRNAs in cancer process. Nuclear receptor subfamily 2 (NR2F2, also known as COUP-TFII) is involved in the development of many types of cancers, but its role in gastric cancer remains elusive. In this experiment, oncomine and Kaplan-meier database revealed that NR2F2 was up-regulated in gastric cancer and that the high NR2F2 expression contributed to poor survival. MicroRNA-27b was targeted and down-regulated by NR2F2 in human gastric cancer tissues and cells. The ectopic expression of miR-27b inhibited gastric cancer cell proliferation and tumor growth in vitroand in vivo. Assays suggested that the overexpression of miR-27b could promote MGC-803 cells’ migration and invasion and retard their metastasis to the liver. In addition, down-regulation of miR-27b enhanced GES-1 cells’ proliferation and metastasis in vitro. These findings reveal that miR-27b is a tumor suppressor in gastric cancer and a biomarker for improving patients’ survival.

Keywords

miR-27b / NR2F2 / gastric cancer / tumor metastasis

References

[1] Aleckovic M, Kang Y (2015) Regulation of cancer metastasis by cellfree miRNAs. Biochim Biophys Acta 1855:24–42

[2] Hawkins SM, Loomans HA, Wan YW, Ghosh-Choudhury T, Coffey D, Xiao W, Liu Z, Sangi-Haghpeykar H, Anderson ML (2013) Expression and functional pathway analysis of nuclear receptor NR2F2 in ovarian cancer. J Clin Endocrinol Metab 98:E1152–E1162

[3] Huang CY, Chang AC, Chen HT, Wang SW, Lo YS, Tang CH (2016) Adiponectin promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-27b through CaMKII/AMPK/p38 signaling pathway in human chondrosarcoma cells. Clin Sci 130(17):1523–1533

[4] Kang W, Tong JH, Chan AW, Zhao J, Dong Y, Wang S, Yang W, Sin FM, Ng SS, Yu J(2014) Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. J Trans Med 12:80

[5] Kieback DG, Levi T, Kohlberger P, Fiedrich U, Press MF, Rosenthal HE, Mobus VJ, Runnebaum IB, Tong XW, Tsai MJ (1996) Chicken ovalbumin upstream promoter–transcription factor (COUP-TF) expression in human endometrial cancer cell lines. Anticancer Res 16:3371–3376

[6] Lee JJ, Drakaki A, Iliopoulos D, Struhl K (2012) MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene 31:3818–3825

[7] Lin Y, Liu AY, Fan C, Zheng H, Li Y, Zhang C, Wu S, Yu D, Huang Z, Liu F (2015) MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci Rep 5:9995

[8] Liu AY, Cai Y, Mao Y, Lin Y, Zheng H, Wu T, Huang Y, Fang X, Lin S, Feng Q (2014) Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. Carcinogenesis 35:537–545

[9] Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688

[10] Milne AN, Carneiro F, O’Morain C, Offerhaus GJ (2009) Nature meets nurture: molecular genetics of gastric cancer. Human Genet 126:615–628

[11] Prahalad P, Dakshanamurthy S, Ressom H, Byers SW (2010) Retinoic acid mediates regulation of network formation by COUPTFII and VE-cadherin expression by TGFbeta receptor kinase in breast cancer cells. PloS ONE 5:e10023

[12] Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY (2010) Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res 70:8812–8821

[13] Qin J, Wu SP, Creighton CJ, Dai F, Xie X, Cheng CM, Frolov A, Ayala G, Lin X, Feng XH (2013) COUP-TFII inhibits TGFbeta-induced growth barrier to promote prostate tumorigenesis. Nature 493:236–240

[14] Ruan K, Fang X, Ouyang G (2009) MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 285:116–126

[15] Shin SW, Kwon HC, Rho MS, Choi HJ, Kwak JY, Park JI (2009) Clinical significance of chicken ovalbumin upstream promotertranscription factor II expression in human colorectal cancer. Oncol Rep 21:101–106

[16] Tao J, Zhi X, Zhang X, Fu M, Huang H, Fan Y, Guan W, Zou C (2015) miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. J Exp Clin Cancer Res 34:139

[17] Tsai SY, Tsai MJ (1997) Chick ovalbumin upstreampromoter-transcription factors (COUP-TFs): coming of age. Endocr Rev 18:229–240

[18] Yan Y, Wang LF, Wang RF (2015) Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer. World J Gastroenterol 21:9717–9726

[19] Yao J, Deng B, Zheng L, Dou L, Guo Y, Guo K (2016) miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition. Oncol Rep 35:1645–1651

[20] Zhang J, Ma L (2012) MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 31:653–662

[21] Zhang C, Han Y, Huang H, Qu L, Shou C (2014a) High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-beta-dependent epithelial-mesenchymal transition in breast cancer. Breast Cancer Res Treat 147:265–281

[22] Zhang Y, Yang P, Wang XF (2014b) Microenvironmental regulation of cancer metastasis by miRNAs. Trends Cell Biol 24:153–160

[23] Zheng L, Baumann U, Reymond JL (2004) An efficient one-step sitedirected and site-saturation mutagenesis protocol. Nucleic Acids Res 32:e115

[24] Zhou B, Song J, Han T, Huang M, Jiang H, Qiao H, Shi J, Wang Y (2016) MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer. Mol Carcinog.

RIGHTS & PERMISSIONS

The Author(s) 2016. This article is published with open access at Springerlink.com and journal.hep.com.cn